Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Actelion hits 6-yr high after favourable FDA approval for drug
Yahoo/Reuters
Monday, October 21, 2013 - 8:36am
tags:
FDA, Actelion, Opsumit, PAH
3 Things to Watch in Amgen's Earnings Report
Motley Fool
Monday, October 21, 2013 - 8:35am
tags:
earnings, Amgen
The 3 Best-Selling Drugs in the World
Motley Fool
Monday, October 21, 2013 - 8:24am
tags:
AbbVie, Humira, Remicade, JNJ, GSK, Advair
China Biotech In Review: WuXi Laboratory The Only CLIA-Certified Clinical Lab In China
Seeking Alpha
Sunday, October 20, 2013 - 2:47pm
tags:
China, Eddingpharm, Ablynx, Dance Biopharm, Miraculins, Cachet Pharma, CardioKinetix, WuXi PharmaTech
The Next Cholesterol-Fighting Blockbuster Drug?
Motley Fool
Sunday, October 20, 2013 - 2:44pm
tags:
cholesterol, hypercholesterolemia, Regeneron, Sanofi, alirocumab
ImmunoGen, Inc. Announces SAR566658 Clinical Findings Reported at AACR-NCI-EORTC Conference
Yahoo/BusinessWire
Sunday, October 20, 2013 - 2:37pm
tags:
SAR566658, Immunogen, ovarian cancer, breast cancer, skin cancer
Five Data Presentations on BioMarin's BMN 673 PARP Inhibitor at the 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Yahoo/Globe Newswire
Sunday, October 20, 2013 - 2:29pm
tags:
Biomarin, BMN 673, solid tumors
What Was Behind Anacor's 28% Climb?
Motley Fool
Sunday, October 20, 2013 - 2:26pm
tags:
Anacor
Iroko Pharmaceuticals Receives FDA Approval for ZORVOLEX
Pipeline Review
Saturday, October 19, 2013 - 4:14pm
tags:
Iroko Pharmaceuticals, Zorvolex, pain management, NSAIDs
The Growing Role of Medical Science Liaisons in the Pharmaceutical Industry By Best Practices, LLC
Sacramento Bee, CA
Saturday, October 19, 2013 - 4:12pm
tags:
medical science liasons
Pfizer: The Menopause Opportunity
Seeking Alpha
Saturday, October 19, 2013 - 4:01pm
tags:
Pfizer, Duavee, menopause
Portola Prices Public Offering
Yahoo/Zacks
Saturday, October 19, 2013 - 4:00pm
tags:
Portola Pharmaceuticals, IPOs
GlaxoSmithKline: Why This Drug Manufacturer Belongs In Everybody's Portfolio
Seeking Alpha
Saturday, October 19, 2013 - 3:58pm
tags:
GSK
Pfizer Reports Top-Line Results From Two Lyrica® Capsules CV Phase 3b Studies
Yahoo/BusinessWire
Saturday, October 19, 2013 - 3:56pm
tags:
Lyrica, Pfizer, fibromyalgia, diabetic neuropathy
Earnings Preview: Amgen to report 3Q results
Yahoo/AP
Saturday, October 19, 2013 - 3:54pm
tags:
earnings, Amgen
What Was Behind Ariad's 40% Drop?
Motley Fool
Saturday, October 19, 2013 - 3:52pm
tags:
Ariad Pharmaceuticals
Vertex reports positive results from Phase 2 study of VX-509
Yahoo/The Fly on the Wall
Saturday, October 19, 2013 - 3:51pm
tags:
Vertex Pharmaceuticals, VX-509, rheumatoid arthritis
Senesco Announces Reverse Stock Split
Yahoo/BusinessWire
Saturday, October 19, 2013 - 3:48pm
tags:
Senesco
Girard Gibbs LLP Announces Investigation of ARIAD (ARIA) Pharmaceuticals, Inc.
Yahoo/BusinessWire
Saturday, October 19, 2013 - 3:45pm
tags:
Ariad Pharmaceuticals, lawsuits
Ariad Declines After Stopping Iclusig Study on Clot Risk
Bloomberg
Saturday, October 19, 2013 - 3:43pm
tags:
Ariad Pharmaceuticals, Iclusig, chronic myeloid leukemia, leukemia

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.